Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

I think I've been pretty consistent in my complaints since this deal came to light:

$800 million in debt,
~10 million new shares printed and dumped on the market,
Enhanze deals few and far between,
Violation of Helen's assurances that no new financings were on the horizon.

This is not the clearly defined business model that caused institutions to buy over 90% of HALO and run it up to the mid $50's.

If you are convinced that we'll meet your prophecy of advancing into the high $70's your'll have to explain to me how that will be accomplished beyond pointing to past precedent which doesn't apply today.